{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:57:33Z","timestamp":1781650653358,"version":"3.54.5"},"reference-count":189,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Capacity Building Project of Xiyuan Hospital, China Academy of Chinese Medical Sciences","award":["XYZX0301-12"],"award-info":[{"award-number":["XYZX0301-12"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Because the clinical diagnosis of Alzheimer\u2019s disease (AD) still relies largely on cognitive decline and A\/T\/N biomarkers remain costly and invasive, we aimed to identify literature-derived serum microRNAs (miRNAs) associated with cognitive function in AD and to re-evaluate them in a large public cohort (GSE120584) as potential adjunctive diagnostic biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched Chinese- and English-language databases for studies reporting serum miRNA expression in patients with AD and its association with cognitive scale scores. Functional target genes were retrieved from miRTarBase, protein\u2013protein interaction (PPI) networks were constructed using STRING, and functional modules were identified with the Cytoscape plug-in MCODE. Enrichment analyses were then performed for Gene Ontology (GO), KEGG, Reactome, and Hallmark gene sets. Differential expression analysis of GSE120584 was conducted using limma, and partial correlations between miRNA expression and age, sex, and apolipoprotein E \u03b54 (APOE \u03b54) allele count were calculated. Based on the correlation structure and nested cross-validation, optimal miRNA combinations were selected, and multiple diagnostic models were developed using age and sex as baseline clinical predictors. Model performance was evaluated using receiver operating characteristic (ROC) and precision-recall (PR) curves, calibration curves, and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-three publications including 2,458 patients with AD and 2,139 controls were ultimately included. Twenty-two differentially expressed serum miRNAs were identified, of which 15 were positively and 7 were negatively correlated with Mini-Mental State Examination (MMSE) scores. Target genes of positively correlated miRNAs were enriched in PI3K\/AKT\/mTOR, Wnt, and TNF-\u03b1\/NF-\u03baB signaling pathways, whereas target genes of negatively correlated miRNAs were mainly involved in cell cycle regulation, the G2\/M checkpoint, and oxidative stress responses. After matching literature-derived miRNAs with GSE120584 and expanding the candidate miRNA set, 25 significantly differentially expressed miRNAs were identified. Correlation-network analysis combined with nested cross-validation indicated that the minimal miRNA signatures with optimal diagnostic value were miR-211-5p alone (K1) and the three-miRNA panel miR-211-5p, miR-128\u20131-5p, and miR-128-3p (K3). When age and sex were added, the \u201cK3\u2009+\u2009age\u2009+\u2009sex\u201d model showed the best performance (area under the curve [AUC]\u2009=\u20090.838, average precision [AP]\u2009=\u20090.934, Brier score\u2009=\u20090.162), yielding the highest sensitivity (0.563) and the best positive predictive value (PPV\u2009=\u20090.954) at specificity\u2009\u2265\u20090.90.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>By integrating published evidence with re-evaluation in a public serum cohort, we found that adding miR-211-5p and a miR-128-related panel to age- and sex-based models provided a modest but consistent improvement in diagnostic discrimination for AD. These miRNAs may serve as adjunctive peripheral blood biomarkers, although their clinical utility requires confirmation in independent external cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-026-02048-x","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:34:38Z","timestamp":1776699278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Literature-derived serum miRNA signatures associated with cognitive decline in Alzheimer\u2019s disease: integrated analysis and machine learning-based diagnostic modeling"],"prefix":"10.1186","volume":"18","author":[{"given":"Zhiyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"2048_CR1","doi-asserted-by":"publisher","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005.","DOI":"10.1016\/j.jalz.2011.03.005"},{"issue":"10284","key":"2048_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4.","journal-title":"Lancet"},{"issue":"3","key":"2048_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.14283\/jpad.2021.15","volume":"8","author":"XX Zhang","year":"2021","unstructured":"Zhang XX, Tian Y, Wang ZT, Ma YH, Tan L, Yu JT. The epidemiology of Alzheimer\u2019s disease modifiable risk factors and prevention. J Prev Alzheimers Dis. 2021;8(3):313\u201321. https:\/\/doi.org\/10.14283\/jpad.2021.15.","journal-title":"J Prev Alzheimers Dis"},{"key":"2048_CR4","doi-asserted-by":"publisher","unstructured":"2020 Alzheimer's disease facts and figures. Alzheimers Dement. 2020. https:\/\/doi.org\/10.1002\/alz.12068. Epub ahead of print. PMID: 32157811.","DOI":"10.1002\/alz.12068"},{"key":"2048_CR5","doi-asserted-by":"publisher","unstructured":"[Blue paper on Alzheimer's disease in China (simplified version)]. Zhonghua Yi Xue Za Zhi. 2024;104(29):2701\u20132727. https:\/\/doi.org\/10.3760\/cma.j.cn12137-20240416-00883.","DOI":"10.3760\/cma.j.cn12137-20240416-00883"},{"issue":"2","key":"2048_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/1556-4029.13885","volume":"64","author":"RW Byard","year":"2019","unstructured":"Byard RW, Langlois NEI. Wandering dementia-a syndrome with forensic implications. J Forensic Sci. 2019;64(2):443\u20135. https:\/\/doi.org\/10.1111\/1556-4029.13885.","journal-title":"J Forensic Sci"},{"issue":"4","key":"2048_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"2048_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):280\u201392. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003.","journal-title":"Alzheimers Dement"},{"key":"2048_CR9","doi-asserted-by":"publisher","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","DOI":"10.1016\/j.jalz.2018.02.018"},{"issue":"4","key":"2048_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389\u2013404. https:\/\/doi.org\/10.1007\/s00401-006-0127-z.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"2048_CR11","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.1007\/s12035-019-1500-y","volume":"56","author":"S Swarbrick","year":"2019","unstructured":"Swarbrick S, Wragg N, Ghosh S, Stolzing A. Systematic Review of miRNA as Biomarkers in Alzheimer\u2019s Disease. Mol Neurobiol. 2019;56(9):6156\u201367. https:\/\/doi.org\/10.1007\/s12035-019-1500-y.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"2048_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1752-8062.2009.00110.x","volume":"2","author":"SA Waldman","year":"2009","unstructured":"Waldman SA, Terzic A. Applications of microRNA in cancer: exploring the advantages of miRNA. Clin Transl Sci. 2009;2(3):248\u20139. https:\/\/doi.org\/10.1111\/j.1752-8062.2009.00110.x.","journal-title":"Clin Transl Sci"},{"issue":"13","key":"2048_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137167","volume":"23","author":"PTB Ho","year":"2022","unstructured":"Ho PTB, Clark IM, Le LTT. MicroRNA-based diagnosis and therapy. Int J Mol Sci. 2022;23(13):7167. https:\/\/doi.org\/10.3390\/ijms23137167.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2048_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-024-01431-7","volume":"40","author":"F Fattahi","year":"2024","unstructured":"Fattahi F, Asadi MR, Abed S, Kouchakali G, Kazemi M, Mansoori Derakhshan S, et al. Blood-based microRNAs as the potential biomarkers for Alzheimer\u2019s disease: evidence from a systematic review. Metab Brain Dis. 2024;40(1):44. https:\/\/doi.org\/10.1007\/s11011-024-01431-7.","journal-title":"Metab Brain Dis"},{"issue":"2","key":"2048_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.nrleng.2023.12.011","volume":"39","author":"WT Zhang","year":"2024","unstructured":"Zhang WT, Zhang GX, Gao SS. The potential diagnostic accuracy of circulating microRNAs for Alzheimer\u2019s disease: a meta-analysis. Neurolog\u00eda (English Edition). 2024;39(2):147\u201359. https:\/\/doi.org\/10.1016\/j.nrleng.2023.12.011.","journal-title":"Neurolog\u00eda (English Edition)"},{"key":"2048_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/15333175211021712","volume":"36","author":"L Lu","year":"2021","unstructured":"Lu L, Dai WZ, Zhu XC, Ma T. Analysis of Serum miRNAs in Alzheimer\u2019s Disease. Am J Alzheimers Dis Other Demen. 2021;36:15333175211021712. https:\/\/doi.org\/10.1177\/15333175211021712.","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"1","key":"2048_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.14283\/jpad.2023.99","volume":"11","author":"A Sadlon","year":"2024","unstructured":"Sadlon A, Takousis P, Evangelou E, Prokopenko I, Alexopoulos P, Udeh-Momoh CM, et al. Association of blood microRNA expression and polymorphisms with cognitive and biomarker changes in older adults. J Prev Alzheimers Dis. 2024;11(1):230\u201340. https:\/\/doi.org\/10.14283\/jpad.2023.99.","journal-title":"J Prev Alzheimers Dis"},{"key":"2048_CR18","first-page":"279","volume":"189","author":"K Pearson","year":"1896","unstructured":"Pearson K. The system of statistics. Philos Trans R Soc Lond A. 1896;189:279\u2013310.","journal-title":"Philos Trans R Soc Lond A"},{"issue":"3-4","key":"2048_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2307\/1422689","volume":"100","author":"C Spearman","year":"1987","unstructured":"Spearman C. The proof and measurement of association between two things. By C. Spearman, 1904. Am J Psychol. 1987;100(3\u20134):441\u201371.","journal-title":"Am J Psychol"},{"issue":"1","key":"2048_CR20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/nar\/gkab1079","volume":"50","author":"HY Huang","year":"2022","unstructured":"Huang HY, Lin YC, Cui S, Huang Y, Tang Y, Xu J, et al. miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 2022;50(1):222\u201330. https:\/\/doi.org\/10.1093\/nar\/gkab1079.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2048_CR21","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2048_CR22","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","journal-title":"Genome Res"},{"issue":"1","key":"2048_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4(1):2. https:\/\/doi.org\/10.1186\/1471-2105-4-2.","journal-title":"BMC Bioinformatics"},{"key":"2048_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-019-0324-7","volume":"2","author":"D Shigemizu","year":"2019","unstructured":"Shigemizu D, Akiyama S, Asanomi Y, Boroevich KA, Sharma A, Tsunoda T, et al. Risk prediction models for dementia constructed by supervised principal component analysis using miRNA expression data. Commun Biol. 2019;2:77. https:\/\/doi.org\/10.1038\/s42003-019-0324-7.","journal-title":"Commun Biol"},{"issue":"1","key":"2048_CR25","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3(1):Article3. https:\/\/doi.org\/10.2202\/1544-6115.1027.","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"1","key":"2048_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-261","volume":"7","author":"ME Ritchie","year":"2006","unstructured":"Ritchie ME, Diyagama D, Neilson J, van Laar R, Dobrovic A, Holloway A, et al. Empirical array quality weights in the analysis of microarray data. BMC Bioinformatics. 2006;7(1):261. https:\/\/doi.org\/10.1186\/1471-2105-7-261.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"2048_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"7","key":"2048_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007. (Epub 2015 Jan 20. PMID: 25605792; PMCID: PMC4402510.).","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2048_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2307\/3001968","volume":"1","author":"F Wilcoxon","year":"1945","unstructured":"Wilcoxon F. Individual comparisons by ranking methods. Biometrics Bulletin. 1945;1(6):80\u20133.","journal-title":"Biometrics Bulletin"},{"key":"2048_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/9781119196037","volume-title":"Nonparametric statistical methods","author":"M Hollander","year":"1999","unstructured":"Hollander M, Wolfe DA. Nonparametric statistical methods. 2nd ed. New York: Wiley; 1999. https:\/\/doi.org\/10.1002\/9781119196037.","edition":"2nd ed"},{"key":"2048_CR31","volume-title":"Python 3 reference manual","author":"G Van Rossum","year":"2009","unstructured":"Van Rossum G, Drake FL. Python 3 reference manual. Scotts Valley (CA): CreateSpace; 2009."},{"issue":"1","key":"2048_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29\u201336. https:\/\/doi.org\/10.1148\/radiology.143.1.7063747.","journal-title":"Radiology"},{"key":"2048_CR33","doi-asserted-by":"publisher","unstructured":"Davis J, Goadrich MH. The relationship between precision-recall and ROC curves. In: Proceedings of the 23rd International Conference on Machine Learning. 2006. https:\/\/doi.org\/10.1145\/1143844.1143874.","DOI":"10.1145\/1143844.1143874"},{"key":"2048_CR34","unstructured":"Kohavi R. A study of cross-validation and bootstrap for accuracy estimation and model selection. In: Proceedings of the 14th International Joint Conference on Artificial Intelligence. Montreal; 1995; 2:1137\u20131145."},{"key":"2048_CR35","doi-asserted-by":"publisher","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32\u20135. https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1%3C;32::AID-CNCR2820030106%3E;3.0.CO;2-3.","DOI":"10.1002\/1097-0142(1950)3:1%3C;32::AID-CNCR2820030106%3E;3.0.CO;2-3"},{"key":"2048_CR36","doi-asserted-by":"publisher","unstructured":"Kornbrot D. Point biserial correlation. In: Wiley StatsRef: Statistics Reference Online. 2014. https:\/\/doi.org\/10.1002\/9781118445112.stat06227.","DOI":"10.1002\/9781118445112.stat06227"},{"key":"2048_CR37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1467-842X.2004.00360.x","volume":"46","author":"K Baba","year":"2004","unstructured":"Baba K, Shibata R, Sibuya M. Partial correlation and conditional correlation as measures of conditional independence. Aust N Z J Stat. 2004;46:657\u201364. https:\/\/doi.org\/10.1111\/j.1467-842X.2004.00360.x.","journal-title":"Aust N Z J Stat"},{"issue":"1","key":"2048_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","volume":"254","author":"S Marino","year":"2008","unstructured":"Marino S, Hogue IB, Ray CJ, Kirschner DE. A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol. 2008;254(1):178\u201396. https:\/\/doi.org\/10.1016\/j.jtbi.2008.04.011. (Epub 2008 Apr 20. PMID: 18572196; PMCID: PMC2570191.).","journal-title":"J Theor Biol"},{"issue":"1","key":"2048_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(1):559. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","journal-title":"BMC Bioinformatics"},{"key":"2048_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-91","volume":"7","author":"S Varma","year":"2006","unstructured":"Varma S, Simon R. Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics. 2006;7:91. https:\/\/doi.org\/10.1186\/1471-2105-7-91.","journal-title":"BMC Bioinformatics"},{"key":"2048_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-84858-7","volume-title":"The elements of statistical learning: data mining, inference, and prediction","author":"T Hastie","year":"2009","unstructured":"Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining, inference, and prediction. 2nd ed. New York: Springer; 2009.","edition":"2nd ed"},{"issue":"2","key":"2048_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou H, Hastie T. Regularization and variable selection via the elastic net. J R Stat Soc Series B Stat Methodol. 2005;67(2):301\u201320. https:\/\/doi.org\/10.1111\/j.1467-9868.2005.00503.x.","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"2048_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF00994018","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes C, Vapnik V. Support-vector networks. Mach Learn. 1995;20:273\u201397. https:\/\/doi.org\/10.1007\/BF00994018.","journal-title":"Mach Learn"},{"key":"2048_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-2440-0","volume-title":"The nature of statistical learning theory","author":"VN Vapnik","year":"1995","unstructured":"Vapnik VN. The nature of statistical learning theory. New York: Springer-Verlag; 1995."},{"issue":"3","key":"2048_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1145\/1961189.1961199","volume":"2","author":"CC Chang","year":"2011","unstructured":"Chang CC, Lin CJ. LIBSVM: a library for support vector machines. ACM Trans Intell Syst Technol. 2011;2(3):27. https:\/\/doi.org\/10.1145\/1961189.1961199.","journal-title":"ACM Trans Intell Syst Technol"},{"key":"2048_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman L. Random forests. Mach Learn. 2001;45:5\u201332. https:\/\/doi.org\/10.1023\/A:1010933404324.","journal-title":"Mach Learn"},{"key":"2048_CR47","doi-asserted-by":"publisher","unstructured":"Chen T, Guestrin C. XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 2016. p. 785\u2013794. https:\/\/doi.org\/10.1145\/2939672.2939785.","DOI":"10.1145\/2939672.2939785"},{"key":"2048_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-16399-0","volume-title":"Clinical prediction models: a practical approach to development, validation, and updating","author":"EW Steyerberg","year":"2019","unstructured":"Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. 2nd ed. Cham: Springer; 2019. https:\/\/doi.org\/10.1007\/978-3-030-16399-0.","edition":"2nd ed"},{"issue":"9","key":"2048_CR49","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1109\/TKDE.2008.239","volume":"21","author":"H He","year":"2009","unstructured":"He H, Garcia EA. Learning from imbalanced data. IEEE Trans Knowl Data Eng. 2009;21(9):1263\u201384. https:\/\/doi.org\/10.1109\/TKDE.2008.239.","journal-title":"IEEE Trans Knowl Data Eng"},{"issue":"6","key":"2048_CR50","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565\u201374. https:\/\/doi.org\/10.1177\/0272989X06295361. (PMID: 17099194; PMCID: PMC2577036.).","journal-title":"Med Decis Making"},{"key":"2048_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6","volume":"352","author":"AJ Vickers","year":"2016","unstructured":"Vickers AJ, Van Calster B, Steyerberg EW. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ. 2016;352:i6. https:\/\/doi.org\/10.1136\/bmj.i6.","journal-title":"BMJ"},{"issue":"1","key":"2048_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s41512-019-0064-7","volume":"3","author":"AJ Vickers","year":"2019","unstructured":"Vickers AJ, van Calster B, Steyerberg EW. A simple, step-by-step guide to interpreting decision curve analysis. Diagn Progn Res. 2019;3(1):18. https:\/\/doi.org\/10.1186\/s41512-019-0064-7.","journal-title":"Diagn Progn Res"},{"issue":"38","key":"2048_CR53","first-page":"8","volume":"54","author":"JT Xiao","year":"2014","unstructured":"Xiao JT, Yu Y, Tan L, et al. Changes in serum miR-9 levels and their significance in patients with Alzheimer\u2019s disease. Shandong Medical Journal. 2014;54(38):8\u201310.","journal-title":"Shandong Medical Journal"},{"issue":"4","key":"2048_CR54","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3233\/JAD-132144","volume":"40","author":"L Tan","year":"2014","unstructured":"Tan L, Yu JT, Tan MS, Liu QY, Wang HF, Zhang W, et al. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer\u2019s disease. J Alzheimers Dis. 2014;40(4):1017\u201327. https:\/\/doi.org\/10.3233\/JAD-132144.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"2048_CR55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/cbf.3184","volume":"34","author":"LH Jia","year":"2016","unstructured":"Jia LH, Liu YN. Downregulated serum miR-223 servers as biomarker in Alzheimer\u2019s disease. Cell Biochem Funct. 2016;34(4):233\u20137. https:\/\/doi.org\/10.1002\/cbf.3184.","journal-title":"Cell Biochem Funct"},{"issue":"4","key":"2048_CR56","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3892\/etm.2019.7855","volume":"18","author":"Q Yang","year":"2019","unstructured":"Yang Q, Zhao Q, Yin Y. miR-133b is a potential diagnostic biomarker for Alzheimer\u2019s disease and has a neuroprotective role. Exp Ther Med. 2019;18(4):2711\u20138. https:\/\/doi.org\/10.3892\/etm.2019.7855. (PMID: 31572518; PMCID: PMC6755445.).","journal-title":"Exp Ther Med"},{"key":"2048_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2019.110814","volume":"130","author":"F Cao","year":"2020","unstructured":"Cao F, Liu Z, Sun G. Diagnostic value of miR-193a-3p in Alzheimer\u2019s disease and miR-193a-3p attenuates amyloid-\u03b2 induced neurotoxicity by targeting PTEN. Exp Gerontol. 2020;130:110814. https:\/\/doi.org\/10.1016\/j.exger.2019.110814.","journal-title":"Exp Gerontol"},{"issue":"3","key":"2048_CR58","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.3892\/etm.2020.8920","volume":"20","author":"X Zhao","year":"2020","unstructured":"Zhao X, Wang S, Sun W. Expression of miR-28-3p in patients with Alzheimer\u2019s disease before and after treatment and its clinical value. Exp Ther Med. 2020;20(3):2218\u201326. https:\/\/doi.org\/10.3892\/etm.2020.8920. (PMID: 32765698; PMCID: PMC7401892.).","journal-title":"Exp Ther Med"},{"issue":"15","key":"2048_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14033\/j.cnki.cfmr.2021.15.003","volume":"19","author":"R Lin","year":"2021","unstructured":"Lin R, Zhang H. Relationship between serum miR-26b and miR-222 expression and cognitive impairment in patients with Alzheimer\u2019s disease. Chin Foreign Med Res. 2021;19(15):7\u20139. https:\/\/doi.org\/10.14033\/j.cnki.cfmr.2021.15.003.","journal-title":"Chin Foreign Med Res"},{"issue":"6","key":"2048_CR60","first-page":"667","volume":"28","author":"K Meng","year":"2021","unstructured":"Meng K, Zhang J, Liu C, et al. Correlation analysis of changes in serum miR-128 and miR-223 expression levels with inflammatory response and cognitive function in patients with different severities of Alzheimer\u2019s disease. Stroke Nervous Dis. 2021;28(6):667\u201371.","journal-title":"Stroke Nervous Dis"},{"issue":"1","key":"2048_CR61","first-page":"25","volume":"28","author":"W Qiao","year":"2021","unstructured":"Qiao W, Chen X, Wang Y. Expression of serum miR-137 and its relationship with prognosis in patients with Alzheimer\u2019s disease. Chin J Neuroimmunol Neurology. 2021;28(1):25\u20139.","journal-title":"Chin J Neuroimmunol Neurology"},{"issue":"2","key":"2048_CR62","doi-asserted-by":"publisher","first-page":"646","DOI":"10.12677\/ACM.2021.112094","volume":"11","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Hou L, Zhong Y, Shen J. miR-320a as a diagnostic biomarker for Alzheimer\u2019s disease and its protective effect against \u03b2-amyloid-induced neurotoxicity. Adv Clin Med. 2021;11(2):646\u201354. https:\/\/doi.org\/10.12677\/ACM.2021.112094.","journal-title":"Adv Clin Med"},{"issue":"10","key":"2048_CR63","first-page":"1652","volume":"27","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Chen Y, Liu Z, et al. Changes in serum miR-137 and ABCA7 levels and their clinical significance in patients with Alzheimer\u2019s disease. Hebei Med J. 2021;27(10):1652\u20137.","journal-title":"Hebei Med J"},{"issue":"8","key":"2048_CR64","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/kjm2.12391","volume":"37","author":"LH Dong","year":"2021","unstructured":"Dong LH, Sun L, Zhang WJ, Wang XY, Li JM. Reduced serum miR-202 may promote the progression of Alzheimer\u2019s disease patients via targeting amyloid precursor protein. Kaohsiung J Med Sci. 2021;37(8):730\u20138. https:\/\/doi.org\/10.1002\/kjm2.12391. (PMID: 34042273; PMCID: PMC11896508.).","journal-title":"Kaohsiung J Med Sci"},{"key":"2048_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2020.111187","volume":"144","author":"Q Liu","year":"2021","unstructured":"Liu Q, Lei C. Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: correlation of serum miR-331-3p levels with diagnosis and severity of Alzheimer\u2019s disease. Exp Gerontol. 2021;144:111187. https:\/\/doi.org\/10.1016\/j.exger.2020.111187.","journal-title":"Exp Gerontol"},{"issue":"16","key":"2048_CR66","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.2217\/bmm-2021-0098","volume":"15","author":"L Liu","year":"2021","unstructured":"Liu L, Liu L, Lu Y, Zhang T, Zhao W. Serum aberrant expression of miR-24-3p and its diagnostic value in Alzheimer\u2019s disease. Biomark Med. 2021;15(16):1499\u2013507. https:\/\/doi.org\/10.2217\/bmm-2021-0098.","journal-title":"Biomark Med"},{"key":"2048_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.135953","volume":"756","author":"H Zhang","year":"2021","unstructured":"Zhang H, Liu W, Ge H, Li K. Aberrant expression of miR-148a-3p in Alzheimer\u2019s disease and its protective role against amyloid-\u03b2 induced neurotoxicity. Neurosci Lett. 2021;756:135953. https:\/\/doi.org\/10.1016\/j.neulet.2021.135953. (PMID: 33979697.).","journal-title":"Neurosci Lett"},{"key":"2048_CR68","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2147\/NDT.S290925","volume":"17","author":"M Zhang","year":"2021","unstructured":"Zhang M, Han W, Xu Y, Li D, Xue Q. Serum miR-128 serves as a potential diagnostic biomarker for Alzheimer\u2019s disease. Neuropsychiatr Dis Treat. 2021;17:269\u201375. https:\/\/doi.org\/10.2147\/NDT.S290925.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"11","key":"2048_CR69","first-page":"1551","volume":"22","author":"T Deng","year":"2022","unstructured":"Deng T, Duan A, Zeng M, et al. Correlation between serum miR-340-5p and APPL1 levels and inflammatory response and cognitive function in elderly patients with Alzheimer\u2019s disease. J Trop Med. 2022;22(11):1551\u20136.","journal-title":"J Trop Med"},{"issue":"17","key":"2048_CR70","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3760\/cma.j.issn.1007-1245.2022.17.018","volume":"28","author":"W Wang","year":"2022","unstructured":"Wang W, Zheng L, Chang L, Guo F. Correlation of serum levels of miRNA-26b, Hcy, and \u03b2-APP with severity of Alzheimer\u2019s disease and clinical significance. Int Med Health Guid News. 2022;28(17):2451\u20135. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-1245.2022.17.018.","journal-title":"Int Med Health Guid News"},{"issue":"24","key":"2048_CR71","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.13241\/j.cnki.pmb.2022.24.014","volume":"22","author":"W Zhou","year":"2022","unstructured":"Zhou W, Niu C, Di P, et al. Relationship of serum miR-137 and miR-138 expression with cognitive impairment and the PI3K\/Akt signaling pathway in peripheral blood lymphocytes in Alzheimer\u2019s disease. Prog Modern Biomed. 2022;22(24):4674\u20138. https:\/\/doi.org\/10.13241\/j.cnki.pmb.2022.24.014.","journal-title":"Prog Modern Biomed"},{"key":"2048_CR72","unstructured":"He X, Wei X, Li J, et al. Changes in serum miR-98\u20135p and miR-142\u20135p levels and their significance in patients with Alzheimer's disease. Shandong Med J. 2023;63(1):28\u201331, 36."},{"key":"2048_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2023.112195","volume":"178","author":"T Wang","year":"2023","unstructured":"Wang T, Zhao W, Liu Y, Yang D, He G, Wang Z. MicroRNA-511-3p regulates A\u03b21-40 induced decreased cell viability and serves as a candidate biomarker in Alzheimer\u2019s disease. Exp Gerontol. 2023;178:112195. https:\/\/doi.org\/10.1016\/j.exger.2023.112195.","journal-title":"Exp Gerontol"},{"issue":"2","key":"2048_CR74","doi-asserted-by":"publisher","first-page":"207","DOI":"10.19723\/j.issn.1671-167X.2024.02.002","volume":"56","author":"L He","year":"2024","unstructured":"He L, Zhang C, Wang J. Correlation of NEAT1 and miR-27a-3p expression in serum and cerebrospinal fluid of patients with Alzheimer\u2019s disease. J Peking Univ (Health Sciences). 2024;56(2):207\u201312. https:\/\/doi.org\/10.19723\/j.issn.1671-167X.2024.02.002.","journal-title":"J Peking Univ (Health Sciences)"},{"issue":"2","key":"2048_CR75","first-page":"129","volume":"39","author":"P Wang","year":"2024","unstructured":"Wang P, Chen C, Jin Y, et al. Serum expression levels of miR-211 and miR-202 in patients with Alzheimer\u2019s disease and their correlations with cognitive function, anxiety and depressive symptoms. J Modern Lab Med. 2024;39(2):129\u201334.","journal-title":"J Modern Lab Med"},{"issue":"2","key":"2048_CR76","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/01.JGP.0000192478.82189.a8","volume":"14","author":"R Perneczky","year":"2006","unstructured":"Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, Kurz A. Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am J Geriatr Psychiatry. 2006;14(2):139\u201344. https:\/\/doi.org\/10.1097\/01.JGP.0000192478.82189.a8.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1-2","key":"2048_CR77","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2013.10.002","volume":"336","author":"L Tan","year":"2014","unstructured":"Tan L, Yu JT, Liu QY, Tan MS, Zhang W, Hu N, et al. Circulating miR-125b as a biomarker of Alzheimer\u2019s disease. J Neurol Sci. 2014;336(1\u20132):52\u20136. https:\/\/doi.org\/10.1016\/j.jns.2013.10.002.","journal-title":"J Neurol Sci"},{"issue":"3","key":"2048_CR78","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.3390\/ijms14035519","volume":"14","author":"G Fu","year":"2013","unstructured":"Fu G, Brki\u0107 J, Hayder H, Peng C. MicroRNAs in human placental development and pregnancy complications. Int J Mol Sci. 2013;14(3):5519\u201344. https:\/\/doi.org\/10.3390\/ijms14035519.","journal-title":"Int J Mol Sci"},{"issue":"30","key":"2048_CR79","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513\u20138. https:\/\/doi.org\/10.1073\/pnas.0804549105. (PMID: 18663219; PMCID: PMC2492472.).","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2048_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167969","volume":"12","author":"C Glinge","year":"2017","unstructured":"Glinge C, Clauss S, Boddum K, Jabbari R, Jabbari J, Risgaard B, et al. Stability of circulating blood-based microRNAs - pre-analytic methodological considerations. PLoS ONE. 2017;12(2):e0167969. https:\/\/doi.org\/10.1371\/journal.pone.0167969.","journal-title":"PLoS ONE"},{"issue":"10","key":"2048_CR81","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997\u20131006. https:\/\/doi.org\/10.1038\/cr.2008.282.","journal-title":"Cell Res"},{"issue":"8","key":"2048_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136133","volume":"10","author":"D Enderle","year":"2015","unstructured":"Enderle D, Spiel A, Coticchia CM, Berghoff E, Mueller R, Schlumpberger M, et al. Characterization of RNA from exosomes and other extracellular vesicles isolated by a novel spin column-based method. PLoS ONE. 2015;10(8):e0136133. https:\/\/doi.org\/10.1371\/journal.pone.0136133.","journal-title":"PLoS ONE"},{"issue":"4","key":"2048_CR83","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41577-022-00763-8","volume":"23","author":"EI Buzas","year":"2023","unstructured":"Buzas EI. The roles of extracellular vesicles in the immune system. Nat Rev Immunol. 2023;23(4):236\u201350. https:\/\/doi.org\/10.1038\/s41577-022-00763-8. (PMID: 35927511; PMCID: PMC9361922.).","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2048_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046957","volume":"7","author":"L Li","year":"2012","unstructured":"Li L, Zhu D, Huang L, Zhang J, Bian Z, Chen X, et al. Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PLoS ONE. 2012;7(10):e46957. https:\/\/doi.org\/10.1371\/journal.pone.0046957. (PMID: 23077538; PMCID: PMC3471944.).","journal-title":"PLoS ONE"},{"issue":"20","key":"2048_CR85","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1093\/nar\/gkq601","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Zhang S, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010;38(20):7248\u201359. https:\/\/doi.org\/10.1093\/nar\/gkq601. (PMID: 20615901; PMCID: PMC2978372.).","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2048_CR86","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","volume":"13","author":"KC Vickers","year":"2011","unstructured":"Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13(4):423\u201333. https:\/\/doi.org\/10.1038\/ncb2210. (Epub 2011 Mar 20. Erratum in: Nat Cell Biol. 2015 Jan;17(1):104. PMID: 21423178; PMCID: PMC3074610.).","journal-title":"Nat Cell Biol"},{"key":"2048_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.948959","volume":"10","author":"D Xu","year":"2022","unstructured":"Xu D, Di K, Fan B, Wu J, Gu X, Sun Y, et al. MicroRNAs in extracellular vesicles: sorting mechanisms, diagnostic value, isolation, and detection technology. Front Bioeng Biotechnol. 2022;10:948959. https:\/\/doi.org\/10.3389\/fbioe.2022.948959.","journal-title":"Front Bioeng Biotechnol"},{"key":"2048_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s41544-019-0039-4","volume":"1","author":"C Zhao","year":"2019","unstructured":"Zhao C, Sun X, Li L. Biogenesis and function of extracellular miRNAs. ExRNA. 2019;1:38. https:\/\/doi.org\/10.1186\/s41544-019-0039-4.","journal-title":"ExRNA"},{"key":"2048_CR89","doi-asserted-by":"publisher","unstructured":"Geekiyanage H, Rayatpisheh S, Wohlschlegel JA, Brown R Jr, Ambros V. Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides. Proc Natl Acad Sci U S A. 2020;117(39):24213\u201323. https:\/\/doi.org\/10.1073\/pnas.2008323117. (Epub 2020 Sep 14. PMID: 32929008; PMCID: PMC7533700.).","DOI":"10.1073\/pnas.2008323117"},{"issue":"19","key":"2048_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26195979","volume":"26","author":"AL Kaysheva","year":"2021","unstructured":"Kaysheva AL, Isaeva AI, Pleshakova TO, Shumov ID, Valueva AA, Ershova MO, et al. Detection of circulating serum microRNA\/protein complexes in ASD using functionalized chips for an atomic force microscope. Molecules. 2021;26(19):5979. https:\/\/doi.org\/10.3390\/molecules26195979.","journal-title":"Molecules"},{"issue":"28","key":"2048_CR91","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41388-024-03076-3","volume":"43","author":"GAD Metcalf","year":"2024","unstructured":"Metcalf GAD. MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances. Oncogene. 2024;43(28):2135\u201342. https:\/\/doi.org\/10.1038\/s41388-024-03076-3. (Epub 2024 Jun 5. PMID: 38839942; PMCID: PMC11226400.).","journal-title":"Oncogene"},{"issue":"4","key":"2048_CR92","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/cvr\/cvw174","volume":"111","author":"R Navickas","year":"2016","unstructured":"Navickas R, Gal D, Laucevi\u010dius A, Taparauskait\u0117 A, Zdanyt\u0117 M, Holvoet P. Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review. Cardiovasc Res. 2016;111(4):322\u201337. https:\/\/doi.org\/10.1093\/cvr\/cvw174. (Epub 2016 Jun 29. PMID: 27357636; PMCID: PMC4996262.).","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2048_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0316-0","volume":"9","author":"KS Sheinerman","year":"2017","unstructured":"Sheinerman KS, Toledo JB, Tsivinsky VG, Irwin D, Grossman M, Weintraub D, et al. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. Alzheimers Res Ther. 2017;9(1):89. https:\/\/doi.org\/10.1186\/s13195-017-0316-0.","journal-title":"Alzheimers Res Ther"},{"key":"2048_CR94","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.trsl.2022.03.008","volume":"247","author":"GE Grieco","year":"2022","unstructured":"Grieco GE, Besharat ZM, Licata G, Fignani D, Brusco N, Nigi L, et al. Circulating microRNAs as clinically useful biomarkers for Type 2 diabetes mellitus: miRNomics from bench to bedside. Transl Res. 2022;247:137\u201357. https:\/\/doi.org\/10.1016\/j.trsl.2022.03.008.","journal-title":"Transl Res"},{"issue":"4","key":"2048_CR95","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00015-23","volume":"36","author":"M Kimura","year":"2023","unstructured":"Kimura M, Kothari S, Gohir W, Camargo JF, Husain S. MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets. Clin Microbiol Rev. 2023;36(4):e0001523. https:\/\/doi.org\/10.1128\/cmr.00015-23. (Epub 2023 Nov 1. PMID: 37909789; PMCID: PMC10732047.).","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"2048_CR96","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jcp.25056","volume":"231","author":"J Wang","year":"2016","unstructured":"Wang J, Chen J, Sen S. MicroRNA as biomarkers and diagnostics. J Cell Physiol. 2016;231(1):25\u201330. https:\/\/doi.org\/10.1002\/jcp.25056.","journal-title":"J Cell Physiol"},{"issue":"1","key":"2048_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03075-8","volume":"14","author":"YB Li","year":"2024","unstructured":"Li YB, Fu Q, Guo M, Du Y, Chen Y, Cheng Y. Micrornas: pioneering regulators in Alzheimer\u2019s disease pathogenesis, diagnosis, and therapy. Transl Psychiatry. 2024;14(1):367. https:\/\/doi.org\/10.1038\/s41398-024-03075-8.","journal-title":"Transl Psychiatry"},{"key":"2048_CR98","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.2147\/IJN.S442876","volume":"19","author":"EY Lin","year":"2024","unstructured":"Lin EY, Hsu SX, Wu BH, Deng YC, Wuli W, Li YS, et al. Engineered exosomes containing microrna-29b-2 and targeting the somatostatin receptor reduce presenilin 1 expression and decrease the \u03b2-amyloid accumulation in the brains of mice with Alzheimer\u2019s disease. Int J Nanomedicine. 2024;19:4977\u201394. https:\/\/doi.org\/10.2147\/IJN.S442876.","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"2048_CR99","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ymthe.2024.01.033","volume":"32","author":"CL Facal","year":"2024","unstructured":"Facal CL, Fern\u00e1ndez Bessone I, Mu\u00f1iz JA, Pereyra AE, Pedroncini O, P\u00e1ez-Paz I, et al. Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice. Mol Ther. 2024;32(4):1080\u201395. https:\/\/doi.org\/10.1016\/j.ymthe.2024.01.033. (Epub 2024 Feb 3. PMID: 38310353; PMCID: PMC11163272.).","journal-title":"Mol Ther"},{"issue":"19","key":"2048_CR100","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.7150\/thno.103596","volume":"14","author":"D Peng","year":"2024","unstructured":"Peng D, Liu T, Lu H, Zhang L, Chen H, Huang Y, et al. Intranasal delivery of engineered extracellular vesicles loaded with mir-206-3p antagomir ameliorates Alzheimer\u2019s disease phenotypes. Theranostics. 2024;14(19):7623\u201344. https:\/\/doi.org\/10.7150\/thno.103596.","journal-title":"Theranostics"},{"issue":"9","key":"2048_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.23","volume":"4","author":"JK Lam","year":"2015","unstructured":"Lam JK, Chow MY, Zhang Y, Leung SW. SiRNA versus miRNA as therapeutics for gene silencing. Mol Ther Nucleic Acids. 2015;4(9):e252. https:\/\/doi.org\/10.1038\/mtna.2015.23.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2048_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00331","volume":"8","author":"Z Meng","year":"2017","unstructured":"Meng Z, Lu M. RNA interference-induced innate immunity, off-target effect, or immune adjuvant? Front Immunol. 2017;8:331. https:\/\/doi.org\/10.3389\/fimmu.2017.00331.","journal-title":"Front Immunol"},{"issue":"9","key":"2048_CR103","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/17460441.2020.1765770","volume":"15","author":"M Segal","year":"2020","unstructured":"Segal M, Slack FJ. Challenges identifying efficacious miRNA therapeutics for cancer. Expert Opin Drug Discov. 2020;15(9):987\u201392. https:\/\/doi.org\/10.1080\/17460441.2020.1765770. (Epub 2020 May 18. PMID: 32421364; PMCID: PMC7415578.).","journal-title":"Expert Opin Drug Discov"},{"issue":"7209","key":"2048_CR104","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature07228","volume":"455","author":"M Selbach","year":"2008","unstructured":"Selbach M, Schwanh\u00e4usser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by micrornas. Nature. 2008;455(7209):58\u201363. https:\/\/doi.org\/10.1038\/nature07228.","journal-title":"Nature"},{"issue":"3","key":"2048_CR105","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00429-012-0431-4","volume":"218","author":"KF Hansen","year":"2013","unstructured":"Hansen KF, Karelina K, Sakamoto K, Wayman GA, Impey S, Obrietan K. miRNA-132: a dynamic regulator of cognitive capacity. Brain Struct Funct. 2013;218(3):817\u201331. https:\/\/doi.org\/10.1007\/s00429-012-0431-4. (Epub 2012 Jun 16. PMID: 22706759; PMCID: PMC3508255.).","journal-title":"Brain Struct Funct"},{"issue":"10","key":"2048_CR106","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.stem.2021.05.001","volume":"28","author":"H Walgrave","year":"2021","unstructured":"Walgrave H, Balusu S, Snoeck S, Vanden Eynden E, Craessaerts K, Thrupp N, et al. Restoring mir-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer\u2019s disease. Cell Stem Cell. 2021;28(10):1805-1821.e8. https:\/\/doi.org\/10.1016\/j.stem.2021.05.001.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2048_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00496-7","volume":"16","author":"H Walgrave","year":"2021","unstructured":"Walgrave H, Zhou L, De Strooper B, Salta E. The promise of microrna-based therapies in Alzheimer\u2019s disease: challenges and perspectives. Mol Neurodegener. 2021;16(1):76. https:\/\/doi.org\/10.1186\/s13024-021-00496-7.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"2048_CR108","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ncrna.2024.02.006","volume":"9","author":"H Casado Gama","year":"2024","unstructured":"Casado Gama H, Amor\u00f3s MA, Andrade de Ara\u00fajo M, Sha CM, Vieira MPS, Torres RGD, et al. Systematic review and meta-analysis of dysregulated microRNAs derived from liquid biopsies as biomarkers for amyotrophic lateral sclerosis. Noncoding RNA Res. 2024;9(2):523\u201335. https:\/\/doi.org\/10.1016\/j.ncrna.2024.02.006. (PMID: 38511059; PMCID: PMC10950706.).","journal-title":"Noncoding RNA Res"},{"issue":"1","key":"2048_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02108-4","volume":"12","author":"V Dobricic","year":"2022","unstructured":"Dobricic V, Schilling M, Schulz J, Zhu LS, Zhou CW, Fu\u00df J, et al. Differential microrna expression analyses across two brain regions in Alzheimer\u2019s disease. Transl Psychiatry. 2022;12(1):352. https:\/\/doi.org\/10.1038\/s41398-022-02108-4.","journal-title":"Transl Psychiatry"},{"issue":"5","key":"2048_CR110","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41380-022-01476-z","volume":"27","author":"S Yoon","year":"2022","unstructured":"Yoon S, Kim SE, Ko Y, Jeong GH, Lee KH, Lee J, et al. Differential expression of MicroRNAs in Alzheimer\u2019s disease: a systematic review and meta-analysis. Mol Psychiatry. 2022;27(5):2405\u201313. https:\/\/doi.org\/10.1038\/s41380-022-01476-z. (Erratum in: Mol Psychiatry. 2022 May;27(5):2635. doi: 10.1038\/s41380-022-01534-6. PMID: 35264731.).","journal-title":"Mol Psychiatry"},{"issue":"11","key":"2048_CR111","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.1002\/alz.14230","volume":"20","author":"S Liu","year":"2024","unstructured":"Liu S, Park T, Kr\u00fcger DM, Pena-Centeno T, Burkhardt S, Schutz AL, et al. Plasma miRNAs across the Alzheimer\u2019s disease continuum: Relationship to central biomarkers. Alzheimers Dement. 2024;20(11):7698\u2013714. https:\/\/doi.org\/10.1002\/alz.14230. (PMID: 39291737; PMCID: PMC11567826.).","journal-title":"Alzheimers Dement"},{"issue":"3","key":"2048_CR112","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3892\/ijmm.2020.4648","volume":"46","author":"Y Li","year":"2020","unstructured":"Li Y, Liu L, Ding X, Liu Y, Yang Q, Ren B. Interleukin-1\u03b2 attenuates the proliferation and differentiation of oligodendrocyte precursor cells through regulation of the microRNA-202-3p\/\u03b2-catenin\/Gli1 axis. Int J Mol Med. 2020;46(3):1217\u201324. https:\/\/doi.org\/10.3892\/ijmm.2020.4648.","journal-title":"Int J Mol Med"},{"issue":"1","key":"2048_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262152","volume":"17","author":"R Harati","year":"2022","unstructured":"Harati R, Hammad S, Tlili A, Mahfood M, Mabondzo A, Hamoudi R. MiR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability. PLoS ONE. 2022;17(1):e0262152. https:\/\/doi.org\/10.1371\/journal.pone.0262152.","journal-title":"PLoS ONE"},{"key":"2048_CR114","unstructured":"Dong LX, Zhang YY, Bao HL, Liu Y, Zhang GW, An FM. LncRNA NEAT1 promotes Alzheimer's disease by down regulating micro-27a-3p. Am J Transl Res. 2021;13(8):8885\u20138896. PMID: 34540002; PMCID: PMC8430163."},{"issue":"11","key":"2048_CR115","doi-asserted-by":"publisher","first-page":"625","DOI":"10.22074\/cellj.2025.2029261.1587","volume":"26","author":"B Jaberian Asl","year":"2025","unstructured":"Jaberian Asl B, Nazeri Z, Pezeshki SP, Kheirollah A, Azizidoost S, Adelipour M, et al. Effect of amyloid beta on cholesterol metabolism-correlated microRNAs in primary cultured astrocytes of C57BL\/6J mice: a focus on CYP46A1 and APOE genes. Cell J. 2025;26(11):625\u201331. https:\/\/doi.org\/10.22074\/cellj.2025.2029261.1587.","journal-title":"Cell J"},{"key":"2048_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2019.101497","volume":"51","author":"B Li","year":"2020","unstructured":"Li B, Huang Z, Meng J, Yu W, Yang H. MiR-202-5p attenuates neurological deficits and neuronal injury in MCAO model rats and OGD-induced injury in Neuro-2a cells by targeting eIF4E-mediated induction of autophagy and inhibition of Akt\/GSK-3\u03b2 pathway. Mol Cell Probes. 2020;51:101497. https:\/\/doi.org\/10.1016\/j.mcp.2019.101497.","journal-title":"Mol Cell Probes"},{"issue":"4","key":"2048_CR117","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2217\/epi-2021-0288","volume":"14","author":"Y Li","year":"2022","unstructured":"Li Y, Jin L, Wang F, Ren L, Pen R, Bo G, et al. Epigenetic axis of SNHG19\/miR-137\/TNFAIP1 modulates amyloid beta peptide 25-35-induced SH-SY5Y cytotoxicity. Epigenomics. 2022;14(4):187\u201398. https:\/\/doi.org\/10.2217\/epi-2021-0288.","journal-title":"Epigenomics"},{"issue":"3","key":"2048_CR118","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.bbrc.2017.06.144","volume":"490","author":"D He","year":"2017","unstructured":"He D, Tan J, Zhang J. MiR-137 attenuates A\u03b2-induced neurotoxicity through inactivation of NF-\u03baB pathway by targeting TNFAIP1 in Neuro2a cells. Biochem Biophys Res Commun. 2017;490(3):941\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.144.","journal-title":"Biochem Biophys Res Commun"},{"key":"2048_CR119","unstructured":"Yang L, Kang K, Lin Y, Wu Y. Up-regulation of miR-137 can inhibit PTN in target manner to regulate PTN\/PTPRZ pathway to prevent cognitive dysfunction caused by propofol. Am J Transl Res. 2020;12(11):7490\u20137500. PMID: 33312384; PMCID: PMC7724353."},{"issue":"3","key":"2048_CR120","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.bbrc.2019.08.033","volume":"518","author":"H Wang","year":"2019","unstructured":"Wang H, Lu B, Chen J. Knockdown of lncRNA SNHG1 attenuated A\u03b225-35-inudced neuronal injury via regulating KREMEN1 by acting as a ceRNA of miR-137 in neuronal cells. Biochem Biophys Res Commun. 2019;518(3):438\u201344. https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.033.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2048_CR121","doi-asserted-by":"publisher","DOI":"10.1007\/s10616-024-00691-6","volume":"77","author":"L Chen","year":"2025","unstructured":"Chen L, Yan X. LncRNA NORAD sponging to miR-26b-5p represses the progression of Alzheimer\u2019s disease in vitro by upregulating MME expression. Cytotechnology. 2025;77(1):41. https:\/\/doi.org\/10.1007\/s10616-024-00691-6. (PMID: 39803415; PMCID: PMC11723864.).","journal-title":"Cytotechnology"},{"issue":"2","key":"2048_CR122","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12031-018-1223-y","volume":"67","author":"E Dursun","year":"2019","unstructured":"Dursun E, Canda\u015f E, Y\u0131lmazer S, Gezen-Ak D. Amyloid beta 1-42 alters the expression of mirnas in cortical neurons. J Mol Neurosci. 2019;67(2):181\u201392. https:\/\/doi.org\/10.1007\/s12031-018-1223-y.","journal-title":"J Mol Neurosci"},{"key":"2048_CR123","doi-asserted-by":"crossref","unstructured":"Zeng L, Jiang H, Ashraf GM, Liu J, Wang L, Zhao K, Liu M, Li Z, Liu R.\u00a0Implications of miR-148a-3p\/p35\/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt\/CREB in Alzheimer's disease. Mol Ther Nucleic Acids. 2021; 29(27):256-275.\u00a0doi: 10.1016\/j.omtn.2021.11.019. Erratum in: Mol Ther Nucleic Acids. 2023 Oct 25;34:102059. doi: 10.1016\/j.omtn.2023.102059. PMID: 35024240; PMCID: PMC8714918.","DOI":"10.1016\/j.omtn.2021.11.019"},{"issue":"6","key":"2048_CR124","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/cbin.11576","volume":"45","author":"X Li","year":"2021","unstructured":"Li X, Zhang J, Yang Y, Wu Q, Ning H. Microrna-340-5p increases telomere length by targeting telomere protein POT1 to improve Alzheimer\u2019s disease in mice. Cell Biol Int. 2021;45(6):1306\u201315. https:\/\/doi.org\/10.1002\/cbin.11576.","journal-title":"Cell Biol Int"},{"issue":"10","key":"2048_CR125","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1038\/s41380-020-00926-w","volume":"26","author":"F Eysert","year":"2021","unstructured":"Eysert F, Coulon A, Boscher E, Vreulx AC, Flaig A, Mendes T, et al. Alzheimer\u2019s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner. Mol Psychiatry. 2021;26(10):5592\u2013607. https:\/\/doi.org\/10.1038\/s41380-020-00926-w. (Erratum in: Mol Psychiatry. 2021 Oct;26(10):5608. doi: 10.1038\/s41380-020-01015-8. PMID: 33144711; PMCID: PMC8758496.).","journal-title":"Mol Psychiatry"},{"issue":"5","key":"2048_CR126","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.7150\/thno.47408","volume":"11","author":"ML Chen","year":"2021","unstructured":"Chen ML, Hong CG, Yue T, Li HM, Duan R, Hu WB, et al. Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer\u2019s disease by enhancing autophagy. Theranostics. 2021;11(5):2395\u2013409. https:\/\/doi.org\/10.7150\/thno.47408.","journal-title":"Theranostics"},{"issue":"4","key":"2048_CR127","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1113\/EP088953","volume":"106","author":"XH Liu","year":"2021","unstructured":"Liu XH, Ning FB, Zhao DP, Chang YY, Wu HM, Zhang WH, et al. Role of miR-211 in a PC12 cell model of Alzheimer\u2019s disease via regulation of neurogenin 2. Exp Physiol. 2021;106(4):1061\u201371. https:\/\/doi.org\/10.1113\/EP088953.","journal-title":"Exp Physiol"},{"key":"2048_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2016.00166","volume":"8","author":"C Fan","year":"2016","unstructured":"Fan C, Wu Q, Ye X, Luo H, Yan D, Xiong Y, et al. Role of miR-211 in neuronal differentiation and viability: implications to pathogenesis of Alzheimer\u2019s disease. Front Aging Neurosci. 2016;8:166. https:\/\/doi.org\/10.3389\/fnagi.2016.00166.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"2048_CR129","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23624","volume":"38","author":"H Chen","year":"2024","unstructured":"Chen H, Huang Z, Lei A, Yu X, Shen M, Wu D. MiRNA-211-5p inhibition enhances the protective effect of hucMSC-derived exosome in A\u03b21-40 -induced SH-SY5Y cells by increasing NEP expression. J Biochem Mol Toxicol. 2024;38(1):e23624. https:\/\/doi.org\/10.1002\/jbt.23624.","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"2048_CR130","doi-asserted-by":"publisher","first-page":"321","DOI":"10.31083\/j.jin.2020.02.1151","volume":"19","author":"R Zhu","year":"2020","unstructured":"Zhu R, Qi X, Liu C, Wang D, Li L, Liu X, et al. The silent information regulator 1 pathway attenuates ROS-induced oxidative stress in Alzheimer\u2019s disease. J Integr Neurosci. 2020;19(2):321\u201332. https:\/\/doi.org\/10.31083\/j.jin.2020.02.1151.","journal-title":"J Integr Neurosci"},{"issue":"5","key":"2048_CR131","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s11011-019-00438-9","volume":"34","author":"Y Fu","year":"2019","unstructured":"Fu Y, Hu X, Zheng C, Sun G, Xu J, Luo S, et al. Intrahippocampal miR-342-3p inhibition reduces \u03b2-amyloid plaques and ameliorates learning and memory in Alzheimer\u2019s disease. Metab Brain Dis. 2019;34(5):1355\u201363. https:\/\/doi.org\/10.1007\/s11011-019-00438-9.","journal-title":"Metab Brain Dis"},{"issue":"3","key":"2048_CR132","doi-asserted-by":"publisher","first-page":"749","DOI":"10.7150\/thno.20183","volume":"8","author":"YY Jung","year":"2018","unstructured":"Jung YY, Kim KC, Park MH, Seo Y, Park H, Park MH, et al. Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice. Theranostics. 2018;8(3):749\u201366. https:\/\/doi.org\/10.7150\/thno.20183.","journal-title":"Theranostics"},{"issue":"4","key":"2048_CR133","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12031-016-0815-7","volume":"60","author":"Q Li","year":"2016","unstructured":"Li Q, Li X, Wang L, Zhang Y, Chen L. Mir-98-5p acts as a target for Alzheimer\u2019s disease by regulating A\u03b2 production through modulating SNX6 expression. J Mol Neurosci. 2016;60(4):413\u201320. https:\/\/doi.org\/10.1007\/s12031-016-0815-7.","journal-title":"J Mol Neurosci"},{"issue":"6","key":"2048_CR134","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100257R","volume":"35","author":"C Song","year":"2021","unstructured":"Song C, Shi J, Xu J, Zhao L, Zhang Y, Huang W, et al. Post-transcriptional regulation of \u03b17 nAChR expression by miR-98-5p modulates cognition and neuroinflammation in an animal model of Alzheimer\u2019s disease. FASEB J. 2021;35(6):e21658. https:\/\/doi.org\/10.1096\/fj.202100257R.","journal-title":"FASEB J"},{"key":"2048_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.136719","volume":"484","author":"HX Zeng","year":"2025","unstructured":"Zeng HX, Qin SJ, Wu QZ, Zeng QG, Li JH, Oudin A, et al. Circular RNA circ_0061183 regulates microglial polarization induced by airborne ultrafine particles in HMC3 cells via sponging miR-98-5p. J Hazard Mater. 2025;484:136719. https:\/\/doi.org\/10.1016\/j.jhazmat.2024.136719. (PMID: 39637799.).","journal-title":"J Hazard Mater"},{"issue":"1","key":"2048_CR136","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3892\/ijmm.2018.3957","volume":"43","author":"FZ Chen","year":"2019","unstructured":"Chen FZ, Zhao Y, Chen HZ. MicroRNA-98 reduces amyloid \u03b2-protein production and improves oxidative stress and mitochondrial dysfunction through the Notch signaling pathway via HEY2 in Alzheimer\u2019s disease mice. Int J Mol Med. 2019;43(1):91\u2013102. https:\/\/doi.org\/10.3892\/ijmm.2018.3957. (Epub 2018 Oct 24. PMID: 30365070; PMCID: PMC6257854).","journal-title":"Int J Mol Med"},{"key":"2048_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00227","volume":"10","author":"J Song","year":"2017","unstructured":"Song J, Kim YK. Identification of the role of mir-142-5p in Alzheimer\u2019s disease by comparative bioinformatics and cellular analysis. Front Mol Neurosci. 2017;10:227. https:\/\/doi.org\/10.3389\/fnmol.2017.00227.","journal-title":"Front Mol Neurosci"},{"key":"2048_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113485","volume":"414","author":"CH Fu","year":"2021","unstructured":"Fu CH, Han XY, Tong L, Nie PY, Hu YD, Ji LL. miR-142 downregulation alleviates the impairment of spatial learning and memory, reduces the level of apoptosis, and upregulates the expression of pCaMKII and BAI3 in the hippocampus of APP\/PS1 transgenic mice. Behav Brain Res. 2021;414:113485. https:\/\/doi.org\/10.1016\/j.bbr.2021.113485. (Epub 2021 Jul 21. PMID: 34302879).","journal-title":"Behav Brain Res"},{"key":"2048_CR139","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.brainresbull.2022.02.016","volume":"192","author":"W Liang","year":"2023","unstructured":"Liang W, Xie Z, Liao D, Li Y, Li Z, Zhao Y, et al. Inhibiting microrna-142-5p improves learning and memory in Alzheimer\u2019s disease rats via targeted regulation of the PTPN1-mediated Akt pathway. Brain Res Bull. 2023;192:107\u201314. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.02.016.","journal-title":"Brain Res Bull"},{"key":"2048_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2021.104614","volume":"99","author":"Y Ding","year":"2022","unstructured":"Ding Y, Luan W, Shen X, Wang Z, Cao Y. LncRNA BDNF-AS as ceRNA regulates the miR-9-5p\/BACE1 pathway affecting neurotoxicity in Alzheimer\u2019s disease. Arch Gerontol Geriatr. 2022;99:104614. https:\/\/doi.org\/10.1016\/j.archger.2021.104614. (PMID: 34990931.).","journal-title":"Arch Gerontol Geriatr"},{"issue":"11","key":"2048_CR141","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1080\/09168451.2020.1797469","volume":"84","author":"J Liu","year":"2020","unstructured":"Liu J, Zuo X, Han J, Dai Q, Xu H, Liu Y, et al. MiR-9-5p inhibits mitochondrial damage and oxidative stress in AD cell models by targeting GSK-3\u03b2. Biosci Biotechnol Biochem. 2020;84(11):2273\u201380. https:\/\/doi.org\/10.1080\/09168451.2020.1797469.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"2048_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02199-8","volume":"23","author":"V Kumbol","year":"2025","unstructured":"Kumbol V, Ivanov A, McGurran H, Sch\u00fcler J, Zhai Y, Ludwik K, et al. Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability. Cell Commun Signal. 2025;23(1):196. https:\/\/doi.org\/10.1186\/s12964-025-02199-8.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2048_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23597-9","volume":"12","author":"M Subramanian","year":"2021","unstructured":"Subramanian M, Hyeon SJ, Das T, Suh YS, Kim YK, Lee JS, et al. UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation. Nat Commun. 2021;12(1):3291. https:\/\/doi.org\/10.1038\/s41467-021-23597-9.","journal-title":"Nat Commun"},{"key":"2048_CR144","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.exer.2019.03.012","volume":"182","author":"SI Choi","year":"2019","unstructured":"Choi SI, Lee B, Woo JH, Jeong JB, Jun I, Kim EK. APP processing and metabolism in corneal fibroblasts and epithelium as a potential biomarker for Alzheimer\u2019s disease. Exp Eye Res. 2019;182:167\u201374. https:\/\/doi.org\/10.1016\/j.exer.2019.03.012.","journal-title":"Exp Eye Res"},{"issue":"33","key":"2048_CR145","doi-asserted-by":"publisher","first-page":"8641","DOI":"10.1523\/JNEUROSCI.0630-16.2016","volume":"36","author":"SE Sim","year":"2016","unstructured":"Sim SE, Lim CS, Kim JI, Seo D, Chun H, Yu NK, et al. The brain-enriched microrna mir-9-3p regulates synaptic plasticity and memory. J Neurosci. 2016;36(33):8641\u201352. https:\/\/doi.org\/10.1523\/JNEUROSCI.0630-16.2016.","journal-title":"J Neurosci"},{"issue":"11","key":"2048_CR146","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.4103\/1673-5374.393102","volume":"19","author":"A Bellver-Sanchis","year":"2024","unstructured":"Bellver-Sanchis A, \u00c1vila-L\u00f3pez PA, Tic I, Valle-Garc\u00eda D, Ribalta-Vilella M, Labrador L, et al. Neuroprotective effects of G9a inhibition through modulation of peroxisome-proliferator activator receptor gamma-dependent pathways by miR-128. Neural Regen Res. 2024;19(11):2532\u201342. https:\/\/doi.org\/10.4103\/1673-5374.393102. (Epub 2024 Jan 8. PMID: 38526289; PMCID: PMC11090428).","journal-title":"Neural Regen Res"},{"issue":"5","key":"2048_CR147","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13144","volume":"19","author":"M Deng","year":"2020","unstructured":"Deng M, Zhang Q, Wu Z, Ma T, He A, Zhang T, et al. Mossy cell synaptic dysfunction causes memory imprecision via miR-128 inhibition of STIM2 in Alzheimer\u2019s disease mouse model. Aging Cell. 2020;19(5):e13144. https:\/\/doi.org\/10.1111\/acel.13144. (Erratum in: Aging Cell. 2021 Mar;20(3):e13327. doi: 10.1111\/acel.13327. PMID: 32222058; PMCID: PMC7253057.).","journal-title":"Aging Cell"},{"issue":"7","key":"2048_CR148","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1111\/cns.14143","volume":"29","author":"S Li","year":"2023","unstructured":"Li S, Poon CH, Zhang Z, Yue M, Chen R, Zhang Y, et al. MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3\u03b2, APPBP2, and mTOR in Alzheimer\u2019s disease. CNS Neurosci Ther. 2023;29(7):1848\u201364. https:\/\/doi.org\/10.1111\/cns.14143. (PMID: 36880288; PMCID: PMC10324361.).","journal-title":"CNS Neurosci Ther"},{"issue":"9","key":"2048_CR149","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3349\/ymj.2018.59.9.1096","volume":"59","author":"L Geng","year":"2018","unstructured":"Geng L, Zhang T, Liu W, Chen Y. Inhibition of miR-128 abates A\u03b2-mediated cytotoxicity by targeting PPAR-\u03b3 via NF-\u03baB inactivation in primary mouse cortical neurons and Neuro2a cells. Yonsei Med J. 2018;59(9):1096\u2013106. https:\/\/doi.org\/10.3349\/ymj.2018.59.9.1096.","journal-title":"Yonsei Med J"},{"issue":"4","key":"2048_CR150","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.3233\/JAD-170156","volume":"59","author":"H Hong","year":"2017","unstructured":"Hong H, Li Y, Su B. Identification of circulating mir-125b as a potential biomarker of Alzheimer\u2019s disease in APP\/PS1 transgenic mouse. J Alzheimers Dis. 2017;59(4):1449\u201358. https:\/\/doi.org\/10.3233\/JAD-170156.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2048_CR151","doi-asserted-by":"publisher","first-page":"228","DOI":"10.18699\/vjgb-24-27","volume":"28","author":"RN Mustafin","year":"2024","unstructured":"Mustafin RN, Khusnutdinova EK. Involvement of transposable elements in Alzheimer\u2019s disease pathogenesis. Vavilovskii Zh Genet Selekts. 2024;28(2):228\u201338. https:\/\/doi.org\/10.18699\/vjgb-24-27.","journal-title":"Vavilovskii Zh Genet Selekts"},{"issue":"1","key":"2048_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s13100-023-00297-3","volume":"14","author":"A Gebrie","year":"2023","unstructured":"Gebrie A. Transposable elements as essential elements in the control of gene expression. Mob DNA. 2023;14(1):9. https:\/\/doi.org\/10.1186\/s13100-023-00297-3.","journal-title":"Mob DNA"},{"key":"2048_CR153","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1186470","volume":"15","author":"T Dawson","year":"2023","unstructured":"Dawson T, Rentia U, Sanford J, Cruchaga C, Kauwe JSK, Crandall KA. Locus specific endogenous retroviral expression associated with Alzheimer\u2019s disease. Front Aging Neurosci. 2023;15:1186470. https:\/\/doi.org\/10.3389\/fnagi.2023.1186470.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"2048_CR154","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202052255","volume":"22","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Saville L, Gollen B, Veronesi AA, Mohajerani M, Joseph JT, et al. Increased Alu RNA processing in Alzheimer brains is linked to gene expression changes. EMBO Rep. 2021;22(5):e52255. https:\/\/doi.org\/10.15252\/embr.202052255. (Epub 2021 Mar 1. PMID: 33645898; PMCID: PMC8097388).","journal-title":"EMBO Rep"},{"issue":"10","key":"2048_CR155","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1016\/j.celrep.2018.05.004","volume":"23","author":"C Guo","year":"2018","unstructured":"Guo C, Jeong HH, Hsieh YC, Klein HU, Bennett DA, De Jager PL, et al. Tau activates transposable elements in Alzheimer\u2019s disease. Cell Rep. 2018;23(10):2874\u201380. https:\/\/doi.org\/10.1016\/j.celrep.2018.05.004.","journal-title":"Cell Rep"},{"issue":"1","key":"2048_CR156","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-024-02835-6","volume":"148","author":"N Roy","year":"2024","unstructured":"Roy N, Haq I, Ngo JC, Bennett DA, Teich AF, De Jager PL, et al. Elevated expression of the retrotransposon\u00a0LINE-1\u00a0drives Alzheimer\u2019s disease-associated microglial dysfunction. Acta Neuropathol. 2024;148(1):75. https:\/\/doi.org\/10.1007\/s00401-024-02835-6.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2048_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22129-9","volume":"12","author":"R Hanna","year":"2021","unstructured":"Hanna R, Flamier A, Barabino A, Bernier G. G-quadruplexes originating from evolutionary conserved L1 elements interfere with neuronal gene expression in Alzheimer\u2019s disease. Nat Commun. 2021;12(1):1828. https:\/\/doi.org\/10.1038\/s41467-021-22129-9.","journal-title":"Nat Commun"},{"issue":"3","key":"2048_CR158","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s11357-022-00580-w","volume":"44","author":"F Macciardi","year":"2022","unstructured":"Macciardi F, M GB, Miramontes R, Boattini A, Taccioli C, Modenini G, et al. A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer\u2019s disease. Geroscience. 2022;44(3):1525\u201350. https:\/\/doi.org\/10.1007\/s11357-022-00580-w. (Epub 2022 May 19. PMID: 35585302; PMCID: PMC9213607).","journal-title":"Geroscience"},{"issue":"6","key":"2048_CR159","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.tig.2005.04.008","volume":"21","author":"NR Smalheiser","year":"2005","unstructured":"Smalheiser NR, Torvik VI. Mammalian microRNAs derived from genomic repeats. Trends Genet. 2005;21(6):322\u20136. https:\/\/doi.org\/10.1016\/j.tig.2005.04.008.","journal-title":"Trends Genet"},{"issue":"6","key":"2048_CR160","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131365","volume":"10","author":"S Qin","year":"2015","unstructured":"Qin S, Jin P, Zhou X, Chen L, Ma F. The role of transposable elements in the origin and evolution of microRNAs in human. PLoS ONE. 2015;10(6):e0131365. https:\/\/doi.org\/10.1371\/journal.pone.0131365.","journal-title":"PLoS ONE"},{"issue":"5","key":"2048_CR161","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrg2337","volume":"9","author":"C Feschotte","year":"2008","unstructured":"Feschotte C. Transposable elements and the evolution of regulatory networks. Nat Rev Genet. 2008;9(5):397\u2013405. https:\/\/doi.org\/10.1038\/nrg2337.","journal-title":"Nat Rev Genet"},{"key":"2048_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00645","volume":"10","author":"K Chalertpet","year":"2019","unstructured":"Chalertpet K, Pin-On P, Aporntewan C, Patchsung M, Ingrungruanglert P, Israsena N, et al. Argonaute 4 as an effector protein in RNA-directed DNA methylation in human cells. Front Genet. 2019;10:645. https:\/\/doi.org\/10.3389\/fgene.2019.00645.","journal-title":"Front Genet"},{"issue":"7","key":"2048_CR163","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/hmg\/ddt569","volume":"23","author":"RM Spengler","year":"2014","unstructured":"Spengler RM, Oakley CK, Davidson BL. Functional microRNAs and target sites are created by lineage-specific transposition. Hum Mol Genet. 2014;23(7):1783\u201393. https:\/\/doi.org\/10.1093\/hmg\/ddt569. (Epub 2013 Nov 13. PMID: 24234653; PMCID: PMC3943519).","journal-title":"Hum Mol Genet"},{"issue":"9","key":"2048_CR164","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1261\/rna.079100.122","volume":"28","author":"CJ Playfoot","year":"2022","unstructured":"Playfoot CJ, Sheppard S, Planet E, Trono D. Transposable elements contribute to the spatiotemporal microRNA landscape in human brain development. RNA. 2022;28(9):1157\u201371. https:\/\/doi.org\/10.1261\/rna.079100.122. (Epub 2022 Jun 22. PMID: 35732404; PMCID: PMC9380744).","journal-title":"RNA"},{"issue":"4","key":"2048_CR165","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/14737159.2020.1731306","volume":"20","author":"F Baldacci","year":"2020","unstructured":"Baldacci F, Mazzucchi S, Della Vecchia A, Giampietri L, Giannini N, Koronyo-Hamaoui M, et al. The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases. Expert Rev Mol Diagn. 2020;20(4):421\u201341. https:\/\/doi.org\/10.1080\/14737159.2020.1731306. (Epub 2020 Feb 27. PMID: 32066283; PMCID: PMC7445079).","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"2048_CR166","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.biopsych.2020.01.016","volume":"88","author":"M Habes","year":"2020","unstructured":"Habes M, Grothe MJ, Tunc B, McMillan C, Wolk DA, Davatzikos C. Disentangling Heterogeneity in Alzheimer\u2019s Disease and Related Dementias Using Data-Driven Methods. Biol Psychiatry. 2020;88(1):70\u201382. https:\/\/doi.org\/10.1016\/j.biopsych.2020.01.016. (Epub 2020 Jan 31. PMID: 32201044; PMCID: PMC7305953).","journal-title":"Biol Psychiatry"},{"issue":"5","key":"2048_CR167","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1093\/brain\/awz384","volume":"143","author":"A Badhwar","year":"2020","unstructured":"Badhwar A, McFall GP, Sapkota S, Black SE, Chertkow H, Duchesne S, et al. A multiomics approach to heterogeneity in Alzheimer\u2019s disease: focused review and roadmap. Brain. 2020;143(5):1315\u201331. https:\/\/doi.org\/10.1093\/brain\/awz384.","journal-title":"Brain"},{"issue":"7","key":"2048_CR168","doi-asserted-by":"publisher","first-page":"e698","DOI":"10.1212\/WNL.0000000000200699","volume":"99","author":"S Grover","year":"2022","unstructured":"Grover S, Kumar Sreelatha AA, Pihlstrom L, Domenighetti C, Schulte C, Sugier PE, et al. Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease: Evidence From the COURAGE-PD Consortium. Neurology. 2022;99(7):e698\u2013710. https:\/\/doi.org\/10.1212\/WNL.0000000000200699. (Epub 2022 May 26. PMID: 35970579; PMCID: PMC9484604).","journal-title":"Neurology"},{"issue":"1","key":"2048_CR169","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3233\/JPD-212851","volume":"12","author":"C Domenighetti","year":"2022","unstructured":"Domenighetti C, Sugier PE, Sreelatha AAK, Schulte C, Grover S, Mohamed O, et al. Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson\u2019s Disease. J Parkinsons Dis. 2022;12(1):267\u201382. https:\/\/doi.org\/10.3233\/JPD-212851. (PMID: 34633332; PMCID: PMC9211765).","journal-title":"J Parkinsons Dis"},{"issue":"2","key":"2048_CR170","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/jnnp-2020-323520","volume":"92","author":"IJ Swift","year":"2021","unstructured":"Swift IJ, Sogorb-Esteve A, Heller C, Synofzik M, Otto M, Graff C, et al. Fluid biomarkers in frontotemporal dementia: past, present and future. J Neurol Neurosurg Psychiatry. 2021;92(2):204\u201315. https:\/\/doi.org\/10.1136\/jnnp-2020-323520.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2048_CR171","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-neuro-082823-020615","volume":"47","author":"B Frost","year":"2024","unstructured":"Frost B, Dubnau J. The role of retrotransposons and endogenous retroviruses in age-dependent neurodegenerative disorders. Annu Rev Neurosci. 2024;47(1):123\u201343. https:\/\/doi.org\/10.1146\/annurev-neuro-082823-020615.","journal-title":"Annu Rev Neurosci"},{"issue":"4-5","key":"2048_CR172","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/s0531-5565(96)00155-6","volume":"32","author":"B Villeponteau","year":"1997","unstructured":"Villeponteau B. The heterochromatin loss model of aging. Exp Gerontol. 1997;32(4\u20135):383\u201394. https:\/\/doi.org\/10.1016\/s0531-5565(96)00155-6. (PMID: 9315443).","journal-title":"Exp Gerontol"},{"key":"2048_CR173","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00274","volume":"4","author":"JG Wood","year":"2013","unstructured":"Wood JG, Helfand SL. Chromatin structure and transposable elements in organismal aging. Front Genet. 2013;4:274. https:\/\/doi.org\/10.3389\/fgene.2013.00274.","journal-title":"Front Genet"},{"issue":"5","key":"2048_CR174","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.celrep.2019.04.003","volume":"27","author":"EY Liu","year":"2019","unstructured":"Liu EY, Russ J, Cali CP, Phan JM, Amlie-Wolf A, Lee EB. Loss of nuclear TDP-43 is associated with decondensation of LINE retrotransposons. Cell Rep. 2019;27(5):1409-1421.e6. https:\/\/doi.org\/10.1016\/j.celrep.2019.04.003.","journal-title":"Cell Rep"},{"issue":"5","key":"2048_CR175","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.jmb.2006.01.089","volume":"357","author":"SL Gasior","year":"2006","unstructured":"Gasior SL, Wakeman TP, Xu B, Deininger PL. The human LINE-1 retrotransposon creates DNA double-strand breaks. J Mol Biol. 2006;357(5):1383\u201393. https:\/\/doi.org\/10.1016\/j.jmb.2006.01.089. (Epub 2006 Feb 9. PMID: 16490214; PMCID: PMC4136747).","journal-title":"J Mol Biol"},{"issue":"3","key":"2048_CR176","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.stem.2017.07.009","volume":"21","author":"CA Thomas","year":"2017","unstructured":"Thomas CA, Tejwani L, Trujillo CA, Negraes PD, Herai RH, Mesci P, et al. Modeling of TREX1-Dependent Autoimmune Disease using Human Stem Cells Highlights L1 Accumulation as a Source of Neuroinflammation. Cell Stem Cell. 2017;21(3):319-331.e8. https:\/\/doi.org\/10.1016\/j.stem.2017.07.009. (Epub 2017 Aug 10. PMID: 28803918; PMCID: PMC5591075).","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2048_CR177","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2012.03.036","volume":"149","author":"V Tarallo","year":"2012","unstructured":"Tarallo V, Hirano Y, Gelfand BD, Dridi S, Kerur N, Kim Y, et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell. 2012;149(4):847\u201359. https:\/\/doi.org\/10.1016\/j.cell.2012.03.036. (Epub 2012 Apr 26. PMID: 22541070; PMCID: PMC3351582).","journal-title":"Cell"},{"issue":"18","key":"2048_CR178","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186562","volume":"21","author":"AL Pfaff","year":"2020","unstructured":"Pfaff AL, Bubb VJ, Quinn JP, Koks S. An increased burden of highly active retrotransposition competent L1s is associated with Parkinson\u2019s disease risk and progression in the PPMI cohort. Int J Mol Sci. 2020;21(18):6562. https:\/\/doi.org\/10.3390\/ijms21186562.","journal-title":"Int J Mol Sci"},{"key":"2048_CR179","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.743797","volume":"15","author":"L Floreani","year":"2022","unstructured":"Floreani L, Ansaloni F, Mangoni D, Agostoni E, Sanges R, Persichetti F, et al. Analysis of LINE1 retrotransposons in Huntington\u2019s disease. Front Cell Neurosci. 2022;15:743797. https:\/\/doi.org\/10.3389\/fncel.2021.743797.","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"2048_CR180","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/mds.30128","volume":"40","author":"Y Fu","year":"2025","unstructured":"Fu Y, Adler GL, Youssef P, Phan K, Halliday GM, Dzamko N, Kim WS. Human Endogenous Retrovirus K in Astrocytes Is Altered in Parkinson\u2019s Disease. Mov Disord. 2025;40(4):683\u201392. https:\/\/doi.org\/10.1002\/mds.30128. Epub 2025 Jan 22. PMID: 39840837; PMCID: PMC12006878.","journal-title":"Mov Disord"},{"issue":"1","key":"2048_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36649-z","volume":"14","author":"YH Chang","year":"2023","unstructured":"Chang YH, Dubnau J. Endogenous retroviruses and TDP-43 proteinopathy form a sustaining feedback driving intercellular spread of Drosophila neurodegeneration. Nat Commun. 2023;14(1):966. https:\/\/doi.org\/10.1038\/s41467-023-36649-z.","journal-title":"Nat Commun"},{"key":"2048_CR182","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/625659","volume":"2015","author":"H Dong","year":"2015","unstructured":"Dong H, Li J, Huang L, Chen X, Li D, Wang T, et al. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer\u2019s Disease. Dis Markers. 2015;2015:625659. https:\/\/doi.org\/10.1155\/2015\/625659. (Epub 2015 May 20. PMID: 26078483; PMCID: PMC4452867).","journal-title":"Dis Markers"},{"issue":"10","key":"2048_CR183","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139233","volume":"10","author":"G Lugli","year":"2015","unstructured":"Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, et al. Plasma exosomal miRNAs in persons with and without Alzheimer disease: altered expression and prospects for biomarkers. PLoS ONE. 2015;10(10):e0139233. https:\/\/doi.org\/10.1371\/journal.pone.0139233.","journal-title":"PLoS ONE"},{"issue":"1","key":"2048_CR184","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-019-0169-5","volume":"8","author":"A G\u00e1mez-Valero","year":"2019","unstructured":"G\u00e1mez-Valero A, Campdelacreu J, Vilas D, Ispierto L, Re\u00f1\u00e9 R, \u00c1lvarez R, et al. Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer\u2019s disease and dementia with Lewy bodies. Transl Neurodegener. 2019;8(1):31. https:\/\/doi.org\/10.1186\/s40035-019-0169-5.","journal-title":"Transl Neurodegener"},{"key":"2048_CR185","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00160","volume":"13","author":"W Wei","year":"2020","unstructured":"Wei W, Wang ZY, Ma LN, Zhang TT, Cao Y, Li H. MicroRNAs in Alzheimer\u2019s disease: function and potential applications as diagnostic biomarkers. Front Mol Neurosci. 2020;13:160. https:\/\/doi.org\/10.3389\/fnmol.2020.00160.","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"2048_CR186","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063232","volume":"23","author":"S Francisco","year":"2022","unstructured":"Francisco S, Martinho V, Ferreira M, Reis A, Moura G, Soares AR, et al. The role of microRNAs in proteostasis decline and protein aggregation during brain and skeletal muscle aging. Int J Mol Sci. 2022;23(6):3232. https:\/\/doi.org\/10.3390\/ijms23063232.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2048_CR187","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5114\/aoms\/80619","volume":"18","author":"C Sun","year":"2021","unstructured":"Sun C, Liu J, Duan F, Cong L, Qi X. The role of the microRNA regulatory network in Alzheimer\u2019s disease: a bioinformatics analysis. Arch Med Sci. 2021;18(1):206\u201322. https:\/\/doi.org\/10.5114\/aoms\/80619.","journal-title":"Arch Med Sci"},{"key":"2048_CR188","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1231486","volume":"14","author":"SZ Abidin","year":"2023","unstructured":"Abidin SZ, Mat Pauzi NA, Mansor NI, Mohd Isa NI, Hamid AA. A new perspective on Alzheimer\u2019s disease: micrornas and circular rnas. Front Genet. 2023;14:1231486. https:\/\/doi.org\/10.3389\/fgene.2023.1231486.","journal-title":"Front Genet"},{"issue":"10","key":"2048_CR189","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1101\/gr.222505.117","volume":"27","author":"Z Liufu","year":"2017","unstructured":"Liufu Z, Zhao Y, Guo L, Miao G, Xiao J, Lyu Y, et al. Redundant and incoherent regulations of multiple phenotypes suggest microRNAs\u2019 role in stability control. Genome Res. 2017;27(10):1665\u201373. https:\/\/doi.org\/10.1101\/gr.222505.117. (Epub 2017 Sep 13. PMID: 28904014; PMCID: PMC5630030.).","journal-title":"Genome Res"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02048-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:25:55Z","timestamp":1781648755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02048-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":189,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2048"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02048-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8620145\/v1","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}